Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-0.02%
NET PROFIT MARGIN AVG 15Y
2.49%
NET PROFIT MARGIN AVG 20Y
2.42%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 752 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Adicet Bio, Inc.
Market Cap
$60.69M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$60.79M
Net Profit Margin
-86687.50%
TTM Avg
-43373.76%
3Y Avg
-21686.88%
5Y Avg
-14457.92%
Market Cap
$61.34M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$60.08M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.66M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.75M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$63.02M
Net Profit Margin
-13.72%
TTM Avg
-20.80%
3Y Avg
-11.88%
5Y Avg
-17.10%
Market Cap
$58.57M
Net Profit Margin
0.00%
TTM Avg
-36932.26%
3Y Avg
-34526.76%
5Y Avg
-23017.84%
Market Cap
$63.78M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2871.11%
5Y Avg
-2144.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | $60.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.79M | -86687.50% | -43373.76% | -21686.88% | -14457.92% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| MiNK Therapeutics, Inc. (INKT)vs › | $60.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| PDS Biotechnology Corporation (PDSB)vs › | $59.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| InterCure Ltd. (INCR)vs › | $63.02M | -13.72% | -20.80% | -11.88% | -17.10% |
| Fractyl Health, Inc. (GUTS)vs › | $58.57M | 0.00% | -36932.26% | -34526.76% | -23017.84% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | -2871.11% | -2144.71% |
| Alps Group Inc (ALPS)vs › | $63.23M | -41.36% | -52.43% | -63.29% | -45.57% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 18.48% |
| 2021-12-31 | -289.19% |
| 2021-09-30 | -408.66% |
| 2021-06-30 | -225.47% |
| 2021-03-31 | 535.52% |
| 2020-12-31 | -165.58% |
| 2020-09-30 | -488.08% |
| 2020-06-30 | -113.26% |
| 2020-03-31 | -224.30% |
| 2019-12-31 | -334.08% |
| 2019-09-30 | 209.71% |
| 2019-06-30 | -80.24% |
| 2019-03-31 | -149.19% |
| 2018-12-31 | 15.79% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 14.90% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 22.08% |
| 2017-03-31 | 2.94% |
| 2016-12-31 | -0.45% |
| 2016-09-30 | 3.43% |
| 2016-06-30 | 4.43% |
| 2016-03-31 | 6.60% |
| 2015-12-31 | 6.28% |
| 2015-09-30 | 6.96% |
| 2015-06-30 | 8.33% |
| 2015-03-31 | 5.77% |
| 2014-12-31 | 5.34% |
| 2014-09-30 | 3.69% |
| 2014-06-30 | 4.30% |
| 2014-03-31 | 4.29% |
| 2013-12-31 | 5.80% |
| 2013-09-30 | 8.77% |
| 2013-06-30 | 4.39% |
| 2013-03-31 | 5.03% |
| 2012-12-31 | 3.96% |
| 2012-09-30 | 4.31% |
| 2012-06-30 | 3.59% |
| 2012-03-31 | 4.43% |
| 2011-12-31 | 4.14% |
| 2011-09-30 | 2.99% |
| 2011-06-30 | 2.88% |
| 2011-03-31 | 3.26% |
| 2010-12-31 | -1.36% |
| 2010-09-30 | 3.19% |
| 2010-06-30 | 4.01% |
| 2010-03-31 | 3.87% |
| 2009-12-31 | -3.53% |
| 2009-09-30 | 1.42% |
| 2009-06-30 | 1.41% |
| 2009-03-31 | 2.42% |
| 2008-12-31 | 1.47% |
| 2008-09-30 | 4.85% |
| 2008-06-30 | 7.62% |
| 2008-03-31 | 3.35% |
| 2007-12-31 | 1.18% |
| 2007-09-30 | 0.00% |
